香港——当香港养和医院从一家中国公司采购其首台高端CT扫描仪时，这座城市最负盛名的医院里，一些放射技师和医生持怀疑态度。他们习惯了成熟西方设备的精准与可靠，对中国机器能提供什么心存疑虑。
HONG KONG -- When Hong Kong Sanatorium & Hospital procured its first high-end CT scanner from a Chinese company, some radiographers and doctors at the city's most prestigious hospital were skeptical. Accustomed to the precision and reliability of established Western devices, they had doubts about what a Chinese machine could deliver.
该院首席战略官陈伟旭表示，这种顾虑并未持续太久。这台由上海联影医疗制造的扫描仪，全身扫描仅需五分钟，而传统PET/CT设备则需要20分钟。在一次影像检查中，它能精准追踪全身微小的早期癌变病灶和隐匿的转移癌细胞，助力有效诊断，帮助医生制定精准治疗方案。
The misgivings did not last long, said the hospital's chief strategy officer, Chen Wei-Hsu. The scanner, manufactured by Shanghai-based United Imaging Healthcare, performs full-body scans in five minutes, versus 20 minutes for conventional PET/CT equipment. In a single imaging examination, it can accurately track small early-stage cancer lesions and hidden metastatic cancer cells throughout the body, enabling effective diagnoses and helping physicians make precision treatment plans.
这台设备安置于养和医疗集团东区医疗中心，于上月成为同类产品在香港投入使用的首例。
The machine, housed at HKSH Medical Group's Eastern Medical Center, became the first of its kind to come online in Hong Kong last month.
数十年来，香港私立医院从通用医疗、西门子医疗、飞利浦和奥林巴斯等美国、欧洲和日本顶尖公司的产品目录中采购医疗器械设备。但中国医疗设备制造商正日益向老牌全球品牌发起挑战，将中国向制造业价值链高端攀升的推力延伸至电动汽车和机器人等领域之外。
For decades, Hong Kong's private hospitals have purchased their medical devices and equipment from the catalogues of top American, European and Japanese companies like GE HealthCare, Siemens Healthineers, Philips and Olympus. But Chinese medical equipment makers are increasingly challenging established global brands, extending China's push up the manufacturing value chain beyond sectors such as electric vehicles and robotics.
据中国医药保健品进出口商会数据，2025年，在中国多年政策扶持建设该行业后，中国医院诊疗设备出口额达240.6亿美元，同比增长8.1%。手术机器人出口额飙升368.1%。
In 2025, after years of policy support to build up the sector, China's exports of hospital diagnostic and treatment equipment reached $24.06 billion, up 8.1% on the year. Exports of surgical robots soared by 368.1%, according to the China Chamber of Commerce for Import & Export of Medicines & Health Products.
香港医院高管表示，中国制造商赢得客户，不仅靠更低的价格，还靠其质量、适应性和对客户需求的响应速度。
Hospital executives in Hong Kong said that Chinese manufacturers have won over customers not only with lower prices but also their quality, adaptability and responsiveness to customer needs.
陈志明告诉《日经亚洲》，香港养和医院在购买CT扫描仪前“做了大量研究”。他表示，决定并非基于价格，因为在这种情况下，联影医疗的高端产品与更知名的西方公司产品之间的差价“微乎其微”。香港养和医院最近开始使用这台来自上海联影医疗的扫描仪。（香港养和医院供图）香港港安医院首席运营官陈志明也对中国医疗科技给予高度评价。
Chen told Nikkei Asia that HKSH "did a lot of research" before buying the CT scanner. He said it was not decided by price, since in this case the difference between United Imaging's high-end product and those from better-known Western companies was "negligible." Hong Kong Sanatorium & Hospital recently started using this scanner from Shanghai-based United Imaging Healthcare. (HKSH) Andy Chen, chief operating officer of Hong Kong Adventist Hospital, also spoke highly of Chinese medical tech.
“据我所知，不仅是我们，香港其他医院也在使用中国产的病人监护系统，”他说。“它们已清楚展现良好成效，有强有力的证据支持，且具备成本效益和先进技术，所以我们肯定会采用。”据陈志明透露，港安医院还将引进中国产的手术机器人系统，这也是香港的首例。“虽然成本是一个因素，但质量和性能是我们选择过程的主要驱动力，”他说。
"I know that not only us, but also other hospitals here are using Chinese-made patient monitoring systems," he said. "They have clearly demonstrated good results, supported by strong evidence, cost-effectiveness and advanced technology, so we definitely adopt them." Adventist is also bringing in a Chinese-made surgical robotic system, another first in Hong Kong, according to Chen. "While cost is a factor, quality and performance are the primary drivers of our selection process," he said.
“我们希望提供最优质的解决方案。”港怡医院是该市另一家备受推崇的医院，于1月与深圳超声设备制造商迈瑞医疗签署合作伙伴关系。该院首席执行官兼IHH Healthcare北亚区首席执行官曾嘉荣医生告诉《日经亚洲》，迈瑞的超声设备比同类西方品牌便宜20%至30%。他表示，另一个关键考量是，当设备故障时，中国供应商能比西方同行快得多地提供替换零件，后者需要数周甚至数月。
"We want to deliver the best available solutions." Gleneagles Hospital Hong Kong, another well-regarded hospital in the city, inked a partnership with Shenzhen-based ultrasound device maker Mindray in January. The hospital's chief executive officer and regional chief executive officer of IHH Healthcare North Asia, Dr. Kenneth Tsang, told Nikkei Asia that Mindray's ultrasound machines are 20% to 30% cheaper than comparable Western brands. Another key consideration is that when a machine breaks, Chinese suppliers can provide replacement parts much more quickly than the weeks or even months it takes for Western counterparts to do so, he said.
港怡医院是马来西亚总部IHH Healthcare旗下的国际品牌，在10个国家运营190家医疗机构，包括89家医院。据曾嘉荣透露，三年前，港怡医院使用的超声设备几乎全来自欧洲或美国制造商。如今中国品牌占比达半数。
Gleneagles, the international brand for Malaysia-headquartered IHH Healthcare, runs 190 medical facilities including 89 hospitals across 10 countries. Three years ago, almost all of the ultrasound devices used at Gleneagles Hospital Hong Kong were from European or U.S. manufacturers, according to Tsang. Now Chinese brands account for half.
“我们不是说要切换供应商，而是要实现多元化，”曾医生说。该医院还在加大推广来自上海供应商微创医疗的中国产心脏支架。此前，它依赖美敦力和波士顿科学等美国公司的供应。
"We're not saying we're switching, but we're diversifying," Tsang said. The hospital is also increasing the promotion of Chinese cardiac stents from Shanghai-based supplier MicroPort. Previously, it relied on supplies from U.S. companies such as Medtronic and Boston Scientific.
香港港安医院的陈医生同意，联影医疗扫描仪的售后服务“反应非常迅速”，该公司在几周内就推出了软件更新。他解释说，虽然港安医院购买的计算机断层扫描系统的硬件“与西方同类产品相当”，但在软件方面，如图像处理和重建，需要进行修改以满足医院的标准。
Chen at HKSH agreed that after-sales service for United Imaging's scanner was "very responsive," with the company pushing out software updates in a matter of weeks. He explained that while the hardware of the computed tomography system HKSH bought "matches its Western counterparts," modifications were needed to meet the hospital's standards on the software front, such as image processing and reconstruction.
中国医疗设备在大陆以外地区的采用日益增加，显示出北京扶持该行业的努力正在见效。
The growing adoption of Chinese medical equipment outside mainland China shows that Beijing's efforts to foster the sector are paying off.
过去几年，中国当局出台政策引导医院采购国产设备。多个地方政府走得更远，规定只要符合要求就必须采购国产品牌，而进口设备则面临更严格的政府采购审查。
In the past few years, Chinese authorities have introduced policies to steer hospitals toward domestic equipment. Several local governments have gone further, mandating that homegrown brands be procured whenever they meet requirements, while imports face stricter government procurement reviews.
截至今年，国产产品——其中一些高端产品仍严重依赖进口零部件——在政府采购中也享有20%的价格优势。这意味着即使它们比进口选项更贵，也能中标。
As of this year, domestically made products -- some of which, at the high end, still rely heavily on imported components -- also receive a 20% price advantage in government procurement. This means they can win a bid even when they are more expensive than imported options.
港怡医院今年早些时候与深圳超声设备制造商迈瑞医疗签署了合作伙伴关系。
Gleneagles Hong Kong Hospital inked a partnership with Shenzhen-based ultrasound device maker Mindray earlier this year.
中国还试图改变公立医院采购设备的方式。7月，政府出台新规，要求公立医疗机构通过集中采购项目购买设备。
China has sought to change how public hospitals purchase equipment as well. In July, the government introduced new rules requiring public medical institutions to buy equipment through centralized procurement programs.
在推动国产设备采购的同时，北京也致力于提升行业创新能力并支持企业“出海”。在国家层面，药品和器械监管部门将医疗机器人、高端影像、AI医疗器械和新型生物材料等领域列为优先发展方向。去年，该部门出台了10项措施，旨在加速新产品上市、支持海外拓展，并深化与国际监管机构的协调，包括国际医疗器械监管机构论坛和全球协调工作组。
Alongside efforts to boost adoption of Chinese equipment, Beijing has worked to enhance the industry's innovation and support its overseas expansion. At the national level, the drug and device regulator has prioritized fields such as medical robots, high-end imaging, AI medical devices and novel biomaterials. Last year, it introduced 10 measures aimed at accelerating the arrival of new products on the market, supporting overseas growth and deepening coordination with international regulators, including the International Medical Device Regulators Forum and the Global Harmonization Working Party.
中国的出口雄心在5月获得额外助力。国家药品监督管理局实施了医疗器械出口新规，专家表示，这有助于使中国与国际惯例接轨，并规范销售证明的发放程序。
China's export ambitions received an additional boost in May. The National Medical Products Administration implemented new rules for medical device exports, which experts say helped to align China with international practices and standardize procedures for issuing sales certificates.
在政策利好的推动下，中国企业正在获得市场份额。在中国国内，高端产品约占医疗器械市场的四分之一。通用医疗、飞利浦和西门子医疗被称为“GPS”三巨头，长期以来控制着该细分市场约70%的份额，特别是在CT扫描仪、MRI系统和大型X射线设备领域。它们依然强势，但其统治地位开始动摇。
Riding this policy tailwind, Chinese players are gaining market Inside China, high-end products account for roughly a quarter of the medical-device market. GE HealthCare, Philips and Siemens Healthineers, known as the "GPS" trio, long controlled about 70% of the segment, particularly in CT scanners, MRI systems and large-scale X-ray equipment. They remain strong, but their dominance is beginning to slip.
据中国医药创新促进会数据，三巨头在中国高端市场的合计份额从2022年的67.1%下降至2025年的61.7%。同期，联影医疗的份额从12.4%上升至18.2%。
According to the China Pharmaceutical Innovation and Research Development Association, the trio's combined share of the Chinese high-end market fell from 67.1% in 2022 to 61.7% in 2025. Over the same period, United Imaging's slice rose from 12.4% to 18.2%.
中国政府制定了鼓励国产医疗设备发展的政策。图为威高集团研发的机器人辅助腹腔镜手术系统，操作医生佩戴3D眼镜而非使用显示器进行操作。
China's government has set policies to encourage the develop of domestic medical equipment. Here, a robot-assisted laparoscopic surgical system developed by Weigao Group is operated using 3D glasses rather than a monitor.
这种寒意正体现在财报中。通用电气（GE）的中国营收占其总营收的11%，2025年下降了5%。飞利浦表示，中国在其总营收中的占比从2023年的7.8%滑落至2025年的6.7%，尽管2024年曾短暂回升。西门子的中国销售额约占其总额的8%，2025财年微降1%。与此同时，联影医疗、迈瑞医疗等企业正在海外市场取得进展。
The chill is showing up in earnings reports. GE's China revenue, which accounts for 11% of its total, fell 5% in 2025. Philips said that China's share of total revenue slid from 7.8% in 2023 to 6.7% in 2025, despite a brief uptick in 2024. Siemens' China sales, representing around 8% of its total, edged down 1% in fiscal year 2025. At the same time, companies such as United Imaging and Mindray are making inroads abroad.
联影医疗成立于2011年，其高管团队中有多名前西门子员工。今年上半年，该公司海外营收达17.7亿元人民币（约2.64亿美元），同比增长逾50%，占总营收的25%。根据公司披露的文件，亚太地区贡献了其海外销售的约57%，北美地区紧随其后，约占24%。
Founded in 2011, United Imaging, which counts a number of former Siemens staffers among its senior executives, generated 1.77 billion yuan ($264 million) in overseas revenue in the first half of this year, up more than 50%, year on year, and accounting for 25% of its total revenue. The Asia-Pacific region contributed about 57% of its foreign sales, followed by North America at roughly 24%, according to company filings.
迈瑞医疗成立于1991年，总部位于深圳。得益于病人监护仪和呼吸机的销售，其营收在疫情期间大幅跃升。尽管其国内销售近期有所下滑，但2026年上半年海外营收达到94.7亿元人民币，首次超过总营收的53%，欧洲和拉美市场增速均超20%。
Mindray, which was established in Shenzhen in 1991, saw revenue jump during the pandemic on sales of patient-monitoring equipment and ventilators. While its domestic sales have declined of late, its overseas revenue reached 9.47 billion yuan in the first half of 2026, exceeding 53% of total revenue for the first time as growth in Europe and Latin America topped 20%.
在8月的财报电话会上，迈瑞高管表示仍有增长空间。他们称，中国占全球医疗器械市场的比重不足20%，而公司海外平均市场份额约为5%。然而，中国企业的全球化雄心仍面临障碍。
In a post-earnings call in August, Mindray executives suggested there is more room for growth. They said China accounts for less than 20% of the global medical-device market, while the company's average overseas market share is about 5%. Chinese players face obstacles to their global ambitions, however.
即使在香港，医院越来越多地采用中国设备，但采用范围相对较窄。香港山医院（HKSH）的陈医生表示，该院主要采购来自内地的医学影像设备。
Even in Hong Kong, where hospitals are increasingly embracing Chinese devices, the scope of adoption has been relatively narrow. HKSH's Chen said the hospital has focused on diagnostic imaging equipment from the mainland.
香港山道医院（HKSH）员工演示由美国 Accuray 公司生产的 Radixact 断层放疗机的使用。（香港山道医院供图）“然后是治疗层面。例如，中国也自行生产直线加速器和其他放疗设备，但我们尚未达到那个阶段，”他说。“未来可能会实现。”
HKSH staff demonstrate the use of a Radixact tomotherapy machine, made by U.S.-based Accuray. (HKSH) Hong Kong Sanatorium & Hospital "Then you have the therapeutic level. For example, China also makes their own linear accelerators and other radiotherapy devices, but we haven't gotten to that stage yet," he said. "It may come in the future."
联合影像（United Imaging）的一位科学家（要求不具名）承认，中国设备在海外推广仍面临困难。“尽管我们在美国各地都设有研发中心，但我们面临的最大挑战之一，是说服海外客户信任中国产品，”这位科学家说。
One scientist at United Imaging, who asked not to be named, conceded that Chinese equipment can still be a hard sell abroad. "Despite the fact that we have R&D centers even in various locations in the U.S., one of the biggest challenges for us is to convince overseas clients to have trust in Chinese products," said the scientist.
“我们瞄准的是高端市场，但在美国，客户为什么要选择我们而不是通用电气（GE）？”他补充道。“他们的研发和销售基础设施都已完备。我们仍有很长的路要走。”
"We are targeting the high-end market, but in the U.S., why would clients choose us over GE?" he added. "Their research and sales infrastructure is all there. We still have a long way to go."